Andre Watson

Andre Watson is the Founder, Chairman & CEO of Ligandal, a precision genetic medicine company, since 2014. Andre is also the Founder & CTO of Stealth since 2020. From 2017, they have been an Advisor at Avro Life Science, and from 2015, they have been a Visiting Scientist at the Buck Institute for Research on Aging. At Ligandal, Andre is focused on delivering a peptide-based cure to the COVID-19 pandemic (SARS-CoV-2 coronavirus) as part of a broader mission of enabling personalized medicine on a global scale through the power of nanomedicine and gene therapies. At Avro Life Science, they are working on developing innovative transdermal delivery technologies.

Andre Watson attended Rensselaer Polytechnic Institute, where they studied Biomedical Engineering - Biomaterials and Nanoengineering - Psychology.